News & Announcements

May 2023 | Statement

FDA advisory committee votes unanimously to recommend Opill for over-the-counter use

May 10, 2023 – Today, in a landmark step for reproductive health, a joint FDA advisory committee voted unanimously to allow a birth control pill to be offered over the counter (OTC). The advisory committee vote reflects the decades of science showing that birth control pills are safe and...

April 2023 | Statement

Ibis responds to federal court decisions on mifepristone registration and availability

Cambridge, MA, April 10, 2023 – On Friday, April 7, 2023, a judge in a Texas federal court released a ruling in Alliance for Hippocratic Medicine v. FDA. The ruling places a stay on the FDA’s approval of mifepristone and seeks to remove it from the market nationwide. The same day...

March 2023 | Media

A new battle in the war on abortion pills

March 2023 | Statement

AMAZE Africa media event amplified sexuality education in Sub-Saharan Africa

Insights from the World Population Review indicate that over 13 million children are born to women who are under 20 years old. Disturbingly, more than 90% of these births (about 12 million) occur in developing countries, with African countries topping the list. To address high rates of teenage...

March 2023 | Statement

Exciting new partnership will advance comprehensive sexuality education in sub-Saharan Africa

Ibis Reproductive Health South Africa is proud to announce its partnership with Advocates For Youth (AFY) as the new Sub-Saharan Africa regional lead for the AMAZE Africa initiative, with the intention of amplifying ongoing efforts in the region to make comprehensive sexuality education resources...

March 2023 | Statement

FDA schedules advisory committee meeting for over-the-counter birth control pill to take place May 9-10

The FDA announced today that an advisory committee meeting is scheduled for May 9 and 10 to review the first-ever application for an over-the-counter birth control pill. In July 2022, HRA Pharma announced it had submitted this application to the FDA to switch Opill, a progestin-only, daily birth...

October 2022 | Statement

Ibis responds to FDA’s announcement to postpone advisory committee meeting for over-the-counter birth control pill

We are frustrated and deeply disappointed by the FDA’s delay of the advisory committee meeting to discuss the application to move a progestin-only birth control pill over the counter (OTC). Birth control pills are safe and effective, and over-the-counter availability would expand equitable...

August 2022 | Statement

New partnership will expand access to comprehensive sexuality education resources in Africa

(Johannesburg, South Africa) – Ibis Reproductive Health, South Africa office is excited to announce a partnership with AMAZE.org , a project of Advocates for Youth implemented in collaboration with organizations around the world. AMAZE.org harnesses the power of digital media to provide...

July 2022 | Media

Let’s talk about Misoprostol—the original abortion pill

July 2022 | Statement

New survey reveals difficulties accessing abortion in Indiana, foreshadows worsening harms now that Roe v. Wade is overturned

With Indiana already ranked #2 in United States for number of restrictive abortion laws, researchers say additional barriers could harm Hoosiers even further (Indianapolis, IN) – Following the US Supreme Court’s decision to overturn Roe v. Wade , a new survey shows that one thing...

July 2022 | Statement

Ibis celebrates the first-ever application for an OTC birth control pill in the United States

For nearly two decades, Ibis Reproductive Health has led a coalition-driven effort involving more than 100 reproductive health, rights, and justice organizations, research and advocacy groups, youth activists, health care providers, prominent medical and health professional associations, regulatory...

June 2022 | Statement

Ibis responds to overturn of Roe v. Wade

Cambridge, MA, June 24, 2022 – Today, the US Supreme Court released a final decision on Dobbs v. Jackson Women’s Health Organization . The decision overturns Roe v. Wade , the ruling that established the constitutional right to abortion in 1973. The case was focused on whether...

News & Announcements

Pages